MEDQ - Medquist Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDQ - Medquist

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Peterson CPA who wrote (30)	2/2/2000 10:28:00 AM
From: Mark Peterson CPA	Read Replies (1) of 42

DLJ upgrades Medquist! RESEARCH ALERT - DLJ raises MedQuist to top pick NEW YORK, Feb 2 (Reuters) - Donaldson Lufkin & Jenrette analyst Steven Halper said Wednesday he raised the rating on electronic medical transcription service provider MedQuist Inc <MEDQ.O> to a top pick from buy and the 12-month price target to $40. Shares were up 2-1/16 at 23-3/16. -- said shares are "extremely" undervalued relative to projected growth in earnings. -- said slight revenue shortfall in fourth quarter was possibly due to hospitals deferring acceptances of transcription reports at the end of 1999 due to Y2K fears. -- said competitive concerns are unwarranted; the potential market opportunity is large enough for several participants. -- said company continues to work on new initiatives to expand beyond transcription. -- said company has great cash flow and balance sheet. REUTERS Rtr 10:12 02-02-00

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next